Neptune secures second krill oil patent in six weeks
The war of words between krill oil rivals Neptune Technologies & Bioressources and Aker Biomarine intensified in November as Neptune further bolstered its intellectual property portfolio after securing a US patent (No. 8,057,825) awarding it the exclusive use of krill extracts in the US as a method for reducing cholesterol, platelet adhesion and plaque formation.
The patent – the second awarded to Neptune in six weeks - was immediately challenged by arch rival Aker Biomarine, which has asked the patent office to re-examine it.